FAQ

Please check this page before contacting program staff.
New questions and answers are added to the bottom of the page as they come in.




Q: I would like to share the ADELANTE program with my friends and colleagues. Is there a flyer with information?

A: Yes.
Click here to download a copy of the Adelante Program Fact Sheet.
Click here to download a copy of the full CFAR Adelante RFA
(NOTE: RFA link will become live when the RFA is released).




Q: May we include more people on our CFAR Adelante team than just the three required members?

A: Yes.
Please note that in any situation in which the CFAR Adelante program provides funding for team members outside a Team's research project budget that funding will only be available to the three required team members: Scholar, Collaborating Partner, CFAR Mentor.




Q: Are people in Puerto Rico eligible to apply for a CFAR Adelante grant as Scholar/PI?

A: Yes, as long as they are a U.S. citizen or permanent resident.
Puerto Ricans by birth have U.S. citizenship. Non-U.S. citizen immigrants to Puerto Rico must be U.S. green card holders (permanent residents).




Q: Are post-doctoral fellows eligible to apply for a CFAR Adelante grant as Scholar/PI?

A: No, unless they have a full-time faculty appointment in place by the time the CFAR Adelante Cohort IV project funding begins (August 1, 2021). A letter from the applicant's future department chair, verifying their faculty position and starting date, must be included in the application package.




Q: Are part-time faculty eligible to apply for a CFAR Adelante grant as Scholar/PI?

A: No, unless they will have a full-time faculty appointment in place by the time the CFAR Adelante Cohort IV project funding begins (August 1, 2021). A letter from the applicant's department chair, verifying their faculty position and starting date as full-time faculty, must be included in the application package.




Q: Am I eligible to apply for a CFAR Adelante grant as Scholar/PI if I have had previous NIH funding (e.g. a K award) in HIV research?

A: Yes, as long as your prior NIH funding has not conferred Independent Investigator status on you. Click here for a list of NIH funding mechanisms that maintain Early Stage Investigator (ESI) status.




Q: I received a [MD, PhD] degree more than 10 years ago but went back to school and recently received an MPH degree. Since an MPH is considered a terminal research degree am I now eligible for ESI status again?

A: No.
For purposes of NIH ESI status, a Master in Public Health (MPH) diploma is considered a terminal research degree only in the absence of a doctoral (including MD) degree.




Q: Am I required to have a CFAR Mentor in place before submitting the Concept Proposal?

A: Yes.
An applicant is required to have both a CFAR Mentor and a Collaborating Partner in place before submitting a Concept Proposal.




Q: Can you send me a list of CFAR mentors?

A: Unfortunately No.
There is no single list of senior CFAR-affiliated faculty across the country who are available to be mentors for CFAR Adelante projects.

Click here to see a list of currently funded CFARs. Each CFAR has a Developmental Core that is tasked with helping to build the HIV research careers of junior faculty at their institution. As a resulty, Developmental Core staff are familiar with the senior faculty at their institution and may be able to help you locate an appropriate mentor.

CFAR Adelante Pre-award Program Coordinator Allison O'Rourke may also be able to help you locate a CFAR mentor.




Q: Must the CFAR Mentor have current NIH funding?

A: No.
A Team's CFAR Mentor must have a history of NIH HIV funding as an "independent investigator" (defined by NIH as having been PI on any of these "R01-equivalent" mechanisms: DP1, DP2, DP5, R01, R37, R56, RF1, RL1, U01 and R35) at some point in the past but they do not need to have a current NIH R01-equivalent grant.




Q: Do I need to include letters of support from both the CFAR Mentor and the Community Partner in my application?

A: Yes.
Those letters let the reviewers know that your Team members are enthusiastic about the project and are aware of what their role in it will be.

NOTE: If you have added additional, optional members to your Team, you will need Letters of Support from them as well.




Q: If I have added an optional member to my team do I need to include a biosketches for them in addition to their Letter of Support?

A: No.
A biosketch is only required for the three required members of the team: The Scholar, the CFAR Mentor, and the Collaborating Partner.




Q: I would like to work with a Mentor who is affiliated with a CFAR but does not hold a faculty appointment at that CFAR's institution. Would they be eligible?

A: Yes.
Any otherwise eligible individual that a CFAR Director considers to be a Member of their CFAR is eligible to serve as a CFAR Mentor. A letter from the CFAR Director documenting the membership status of the named CFAR Mentor must be included in the application packet (see RFA for details).




Q: Do you hold webinars about the CFAR Adelante Program and the Proposal submission process?

A: No.
Instead, we provide instructional videos. Click here for more information.




Q: May I engage in Adelante research activities at international sites?

A: Yes, as long as those study activities comprise only a small subset of your domestic Adelante study.

Please note that any study activities conducted at international sites require international clearance from the NIH. In the past this process has taken anywhere from several weeks to over a year and we are not usually able to predict in advance how long it will take.




Q: May I conduct a clinical trial as part of my Adelante research activities?

A: No.
You can conduct clinical research, but not a clinical trial.

Per the revised NIH definition (NOT-OD-15-015), a "clinical trial" is a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes.

NOTE: Some, but not all, clinical research funded through Adelante will require additional NIH CFAR review. See this NIH CFAR page for more information.




Q: How do I submit my [Concept Proposal / Application] packet?

A: See the website.